Trial NCT04264806

View at ClinicalTrials.gov 
Org. Study IDs: CR108734
Secondary IDs: 2019-003576-40 74494550MDS2001

Last trial update was posted on 2022-05-20

MeSH Interventions

Azacitidine

MeSH Conditions

Leukemia Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, Juvenile Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions


Stopping Reasons

The cusatuzumab MDS strategy is under revision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID